GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Total Current Assets

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Total Current Assets : $464.0 Mil (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Nobel Biocare Holding AG's total current assets for the quarter that ended in Dec. 2013 was $464.0 Mil.


Nobel Biocare Holding AG Total Current Assets Historical Data

The historical data trend for Nobel Biocare Holding AG's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Total Current Assets Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 615.99 564.73 352.25 397.30 463.99

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 615.99 564.73 352.25 397.30 463.99

Nobel Biocare Holding AG Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Nobel Biocare Holding AG's Total Current Assets for the fiscal year that ended in Dec. 2013 is calculated as

Nobel Biocare Holding AG's Total Current Assets for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Nobel Biocare Holding AG  (OTCPK:NBHGF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Nobel Biocare Holding AG's Liquidation Value for the quarter that ended in Dec. 2013 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=252.079-376.462+0.75 * 0+0.5 * 35.629
=-106.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG Total Current Assets Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines